JPMORGAN CHASE & CO - 30 Apr 2025 SCHEDULE 13G/A Report for ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares (ATHE)

Filing Manager
JPMORGAN CHASE & CO
Reporting Manager
JPMORGAN CHASE & CO.
Security
ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares
Symbol
ATHE
Shares outstanding
9,150,873,425 shares
Disclosed Ownership
366,034,937 shares
Ownership
4%
Form type
SCHEDULE 13G/A
Filing time
05 May 2025, 14:03:05 UTC
Date of event
30 Apr 2025
Previous filing
02 May 2025
SEC
View on sec.gov

Sponsored

Quoteable Key Fact

"JPMORGAN CHASE & CO disclosed 4% ownership in ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares (ATHE) on 30 Apr 2025."

Quick Takeaways

  • JPMORGAN CHASE & CO filed SCHEDULE 13G/A for ALTERITY THERAPEUTICS LIMITED American Depositary Shares, each representing 600 Ordinary Shares (ATHE).
  • Disclosed ownership: 4%.
  • Date of event: 30 Apr 2025.

What Changed

  • Previous schedule filing date: 02 May 2025.
  • Current filing was accepted on 05 May 2025, 14:03.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JPMORGAN CHASE & CO. 4% 366,034,937 366,034,937 0 Rachel Tsvaygoft Vice President

Sponsored